Search by Drug Name or NDC

    NDC 63868-0721-24 Pressure Pain Cold PE 325; 10; 100; 5 mg/1; mg/1; mg/1; mg/1 Details

    Pressure Pain Cold PE 325; 10; 100; 5 mg/1; mg/1; mg/1; mg/1

    Pressure Pain Cold PE is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Chain Drug Marketing Association. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 63868-0721
    Product ID 63868-721_e8b85171-dc31-3b61-e053-2a95a90a6bb2
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Pressure Pain Cold PE
    Proprietary Name Suffix n/a
    Non-Proprietary Name ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 325; 10; 100; 5
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Chain Drug Marketing Association
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through n/a

    Package

    NDC 63868-0721-24 (63868072124)

    NDC Package Code 63868-721-24
    Billing NDC 63868072124
    Package 2 BLISTER PACK in 1 CARTON (63868-721-24) / 12 TABLET, COATED in 1 BLISTER PACK
    Marketing Start Date 2014-05-21
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 96666654-43f5-4e09-b24f-850b6757d58b Details

    Revised: 9/2022